When nearly half of all contracts in a government insurance program have faced formal federal enforcement, that statistic alone reframes how the program should be understood — not as a well-policed market with occasional bad actors, but as a system with pervasive compliance failures. For the tens of millions of older adults enrolled in Medicare Advantage, this finding has direct implications for access, coverage denials, and care quality.
Analyzing CMS enforcement data from 2010 through 2023, this cross-sectional study examined 1,173 unique Medicare Advantage contracts across preferred provider organizations and health maintenance organizations. Of these, 493 contracts — 42% — received at least one enforcement action during the study period. A total of 844 enforcement actions were recorded, spanning civil monetary penalties, enrollment suspensions, and contract terminations. Program audits drove the majority of enforcement activity, accounting for roughly 64.5% of all actions. Enforcement intensity was notably uneven across years, with 2012 marking a peak in which 100 contracts received monetary penalties.
This research arrives at a moment when Medicare Advantage enrollment has crossed 50% of all Medicare beneficiaries, representing over $494 billion in annual federal outlays. That scale means compliance failures are not an administrative abstraction — they translate directly into denied claims, delayed authorizations, and coverage gaps for a vulnerable population. What makes this study analytically important is the documentation of the enforcement gap: oversight mechanisms exist but have been applied inconsistently across time and plan type. The data do not tell us whether enforcement actions improved subsequent plan behavior, which is a significant limitation. Nor does this cross-sectional design allow causal inference about which plan characteristics predict violations. Still, the finding that nearly half of contracts have faced enforcement at some point should prompt deeper scrutiny of audit frequency, penalty magnitude relative to plan revenues, and whether current CMS oversight tools carry sufficient deterrent weight.